Ascendiant Capital Markets restated their buy rating on shares of Heart Test Laboratories (NASDAQ:HSCS – Free Report) in a report published on Monday, Benzinga reports. The firm currently has a $15.00 price objective on the stock.
Heart Test Laboratories Price Performance
Shares of Heart Test Laboratories stock opened at $4.87 on Monday. The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08. Heart Test Laboratories has a 52 week low of $2.36 and a 52 week high of $52.00. The stock’s 50-day simple moving average is $3.39 and its 200-day simple moving average is $6.43. The company has a market capitalization of $3.19 million, a price-to-earnings ratio of -0.10 and a beta of 3.13.
About Heart Test Laboratories
Recommended Stories
- Five stocks we like better than Heart Test Laboratories
- How is Compound Interest Calculated?
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- P/E Ratio Calculation: How to Assess Stocks
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.